165 related articles for article (PubMed ID: 32470043)
41. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.
Makhey VD; Guo A; Norris DA; Hu P; Yan J; Sinko PJ
Pharm Res; 1998 Aug; 15(8):1160-7. PubMed ID: 9706044
[TBL] [Abstract][Full Text] [Related]
42. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.
Batrakova EV; Li S; Miller DW; Kabanov AV
Pharm Res; 1999 Sep; 16(9):1366-72. PubMed ID: 10496651
[TBL] [Abstract][Full Text] [Related]
43. Transport of trans-tiliroside (kaempferol-3-β-D-(6"-p-coumaroyl-glucopyranoside) and related flavonoids across Caco-2 cells, as a model of absorption and metabolism in the small intestine.
Luo Z; Morgan MR; Day AJ
Xenobiotica; 2015; 45(8):722-30. PubMed ID: 25761590
[TBL] [Abstract][Full Text] [Related]
44. [Absorption and transport of 6 coumarins isolated from the roots of Angelica pubescens f. biserrata in human Caco-2 cell monolayer model].
Yang XW; Guo QM; Wang Y
Zhong Xi Yi Jie He Xue Bao; 2008 Apr; 6(4):392-8. PubMed ID: 18405608
[TBL] [Abstract][Full Text] [Related]
45. Absorption and transport of pachymic acid in the human intestinal cell line Caco-2 monolayers.
Zheng Y; Yang XW
Zhong Xi Yi Jie He Xue Bao; 2008 Jul; 6(7):704-10. PubMed ID: 18601852
[TBL] [Abstract][Full Text] [Related]
46. Transepithelial transport mechanisms of 7,8-dihydroxyflavone, a small molecular TrkB receptor agonist, in human intestinal Caco-2 cells.
Chen Y; Xue F; Xia G; Zhao Z; Chen C; Li Y; Zhang Y
Food Funct; 2019 Aug; 10(8):5215-5227. PubMed ID: 31384856
[TBL] [Abstract][Full Text] [Related]
47. Modulation of Intestinal Transport and Absorption of Topotecan, a BCRP Substrate, by Various Pharmaceutical Excipients and Their Inhibitory Mechanisms of BCRP Transporter.
Sawangrat K; Yamashita S; Tanaka A; Morishita M; Kusamori K; Katsumi H; Sakane T; Yamamoto A
J Pharm Sci; 2019 Mar; 108(3):1315-1325. PubMed ID: 30389568
[TBL] [Abstract][Full Text] [Related]
48. Black ginger extract and its active compound, 5,7-dimethoxyflavone, increase intestinal drug absorption via efflux drug transporter inhibitions.
Boonnop R; Meetam P; Siangjong L; Tuchinda P; Thongphasuk P; Soodvilai S; Soodvilai S
Drug Metab Pharmacokinet; 2023 Jun; 50():100500. PubMed ID: 36948091
[TBL] [Abstract][Full Text] [Related]
49. Involvement of P-glycoprotein and multidrug resistance associated protein 1 on the transepithelial transport of a mercaptoacetamide-based histone-deacetylase inhibitor in Caco-2 cells.
Konsoula Z; Jung M
Biol Pharm Bull; 2009 Jan; 32(1):74-8. PubMed ID: 19122284
[TBL] [Abstract][Full Text] [Related]
50. The absorption and transport of magnolol in Caco-2 cell model.
Wu AG; Zeng B; Huang MQ; Li SM; Chen JN; Lai XP
Chin J Integr Med; 2013 Mar; 19(3):206-11. PubMed ID: 22903441
[TBL] [Abstract][Full Text] [Related]
51. Transepithelial transport of rosuvastatin and effect of ursolic acid on its transport in Caco-2 monolayers.
Hua WJ; Fang HJ; Hua WX
Eur J Drug Metab Pharmacokinet; 2012 Sep; 37(3):225-31. PubMed ID: 22562361
[TBL] [Abstract][Full Text] [Related]
52. Preclinical pharmacokinetics of PDE-310, a novel PDE4 inhibitor.
Song JS; Rho HJ; Park JS; Kim MS; Lee BH; Seo JW; Jeon DJ; Cheon HG; Ahn SH; Kwon KI; Bae MA
Drug Metab Pharmacokinet; 2011; 26(2):192-200. PubMed ID: 21206135
[TBL] [Abstract][Full Text] [Related]
53. Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers.
Annaert P; Van Gelder J; Naesens L; De Clercq E; Van den Mooter G; Kinget R; Augustijns P
Pharm Res; 1998 Aug; 15(8):1168-73. PubMed ID: 9706045
[TBL] [Abstract][Full Text] [Related]
54. [Absorption and transportation characteristics of scutellarin and scutellarein across Caco-2 monolayer model].
You HS; Zhang HF; Dong YL; Chen SY; Wang MY; Dong WH; Xing JF
Zhong Xi Yi Jie He Xue Bao; 2010 Sep; 8(9):863-9. PubMed ID: 20836977
[TBL] [Abstract][Full Text] [Related]
55. Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress.
Xu H; Shen J; Liu H; Shi Y; Li L; Wei M
Can J Physiol Pharmacol; 2006 Dec; 84(12):1267-73. PubMed ID: 17487235
[TBL] [Abstract][Full Text] [Related]
56. The Hypoglycemic and Synergistic Effect of Loganin, Morroniside, and Ursolic Acid Isolated from the Fruits of Cornus officinalis.
He K; Song S; Zou Z; Feng M; Wang D; Wang Y; Li X; Ye X
Phytother Res; 2016 Feb; 30(2):283-91. PubMed ID: 26619955
[TBL] [Abstract][Full Text] [Related]
57. ABCG2 modulates chlorothiazide permeability--in vitro-characterization of its interactions.
Beéry E; Rajnai Z; Abonyi T; Makai I; Bánsághi S; Erdő F; Sziráki I; Herédi-Szabó K; Kis E; Jani M; Márki-Zay J; Tóth GK; Krajcsi P
Drug Metab Pharmacokinet; 2012; 27(3):349-53. PubMed ID: 22790065
[TBL] [Abstract][Full Text] [Related]
58. In Vitro and In Situ Characterization of the Intestinal Absorption of Capilliposide B and Capilliposide C from
Zhang X; Cheng X; Wu Y; Feng D; Qian Y; Chen L; Yang B; Gu M
Molecules; 2019 Mar; 24(7):. PubMed ID: 30925820
[TBL] [Abstract][Full Text] [Related]
59. Rapid detection of ABC transporter interaction: potential utility in pharmacology.
Robey RW; Lin B; Qiu J; Chan LL; Bates SE
J Pharmacol Toxicol Methods; 2011; 63(3):217-22. PubMed ID: 21112407
[TBL] [Abstract][Full Text] [Related]
60. Morroniside, a secoiridoid glycoside from Cornus officinalis, attenuates neuropathic pain by activation of spinal glucagon-like peptide-1 receptors.
Xu M; Wu HY; Liu H; Gong N; Wang YR; Wang YX
Br J Pharmacol; 2017 Apr; 174(7):580-590. PubMed ID: 28098360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]